Truist Financial
ONC

Truist Financial’s BeOne Medicines Ltd ONC Stock Holding History

Truist Financial’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-683
Closed -$203K – 3027
2026
Q1 		$203K Buy
+683
New +$221K ﹤0.01% 2651
2025
Q4 		– Sell
-641
Closed -$218K – 2876
2025
Q3 		$218K Buy
+641
New +$195K ﹤0.01% 2506
2025
Q2 		– Sell
-1,283
Closed -$349K – 2709
2025
Q1 		$349K Buy
1,283
+76
+6% +$17.8K ﹤0.01% 2068
2024
Q4 		$223K Sell
1,207
-136
-10% -$27.8K ﹤0.01% 2333
2024
Q3 		$302K Sell
1,343
-178
-12% -$32K ﹤0.01% 2125
2024
Q2 		$217K Buy
1,521
+140
+10% +$21.6K ﹤0.01% 2458
2024
Q1 		$216K Buy
1,381
+255
+23% +$41.1K ﹤0.01% 2457
2023
Q4 		$203K Sell
1,126
-2
-0.2% -$362 ﹤0.01% 2494
2023
Q3 		$203K Buy
+1,128
New +$223K ﹤0.01% 2443
2023
Q2 		– Sell
-1,282
Closed -$276K – 2693
2023
Q1 		$276K Buy
1,282
+146
+13% +$35K ﹤0.01% 2278
2022
Q4 		$250K Buy
+1,136
New +$208K ﹤0.01% 2314
2021
Q4 		– Sell
-564
Closed -$205K – 2868
2021
Q3 		$205K Buy
+564
New +$184K ﹤0.01% 2547

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Truist Financial's ONC Position: Q2 2026 in Review

Truist Financial sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 683 shares — an estimated $203K sold.

Truist Financial first reported a position in ONC in Q3 2021 and held it in 12 quarters. The position peaked at $349K in Q1 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Truist Financial reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
  • Truist Financial sold 683 BeOne Medicines Ltd shares in Q2 2026, an estimated $203K.
  • Truist Financial first reported a position in BeOne Medicines Ltd in Q3 2021 and held it in 12 quarters.
  • Truist Financial's BeOne Medicines Ltd position peaked at $349K in Q1 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.